MRIコイルの世界市場-2025～2033年

MRIコイルの世界市場は、2024年に92億6,000万米ドルに達し、2033年には181億8,000万米ドルに達すると予測され、予測期間2025年のCAGRは8.1%で成長する見込みです。

MRIコイルは、磁気共鳴画像装置（MRI）システムの重要なコンポーネントであり、多様な身体領域の高品質な診断画像を可能にします。MRIコイルは、アンテナに似た働きをする特殊な装置です。MRIスキャン中に高周波（RF）信号の発生と受信を助ける1つまたは複数の銅線のループで構成されています。これらのコイルは、強い磁場を受けると体内の原子核から放出される信号を捕らえることができるため、撮像プロセスに不可欠です。

MRIコイルは、MRI装置によって生成されたRF信号を受信し、コンピュータに送信します。コイルには、解剖学的部位に合わせたさまざまなデザインがあります。フレーム状でスキャンする部位にフィットするコイルもあれば、フレキシブルで身体の形状に合わせて調整できるコイルもあります。

市場力学：

促進要因と抑制要因

MRIコイル需要の増加

MRIコイルに対する需要の増加は、世界のMRIコイル市場の成長において重要な要因となることが予想されます。MRIコイルの世界市場は、画像診断に対する需要の増加、慢性疾患の有病率の上昇、技術の進歩、新製品の発売や承認などにより、大きく拡大する見込みです。心血管障害、がん、神経疾患などの慢性疾患は、高齢化、ライフスタイルの変化、環境の影響などにより増加傾向にあります。

例えば、米国疾病予防管理センターによると、20歳以上の成人の約2,010万人が冠動脈疾患を患っており、米国では約7.2％です。National Center for Biotechnology Information,（2023年）によると、骨粗鬆症は世界的にも熱帯諸国においても最も一般的な代謝性骨疾患です。骨粗鬆症の有病率は、閉経後の女性で30～50％、50歳以上の男性で最大20％です。さらに、世界保健機関（WHO）によると、2023年には、がん、慢性閉塞性肺疾患、喘息、糖尿病、心血管疾患などの疾病が低・中所得国の人々に影響を及ぼし、世界のNCDによる死亡の4分の3以上（3,140万人）が発生し、その80％を占めています。約1,700万人が70歳までにNCDで死亡しています。このような疾患の有病率の増加には、患者の健康状態を深く洞察できる画像診断技術の向上が必要であり、MRIは現代医療に不可欠なツールとなっています。慢性疾患の増加に伴い、ヘルスケア機関では診断精度と治療計画を向上させるためにMRI技術の導入が進んでいます。

MRIコイル市場は、これらの装置の設計や機能性を向上させる技術的改良によっても牽引されています。より高い信号対雑音比（SNR）やスキャン時間の短縮などの技術革新により、MRIスキャンはより効率的かつ効果的になっています。メーカーが特定の用途に特化した新しい高周波（RF）コイルや勾配コイルを開発するにつれて、複雑な慢性疾患の特定に不可欠な画質が向上しています。さらに、高磁場MRIシステム（3Tや7Tなど）の導入により、より鮮明で詳細な画像が得られるようになり、慢性疾患に伴う微妙な変化を検出するのに不可欠な撮像能力が向上します。

例えば、2023年11月、医療技術の世界的パイオニアであるRoyal Philipsは、それぞれの使用目的に最適な3種類の新しいMRスマートフィットコイルを発売しました。RFコイルはすべてのMRI検査の基本的な構成要素です。この新しい超軽量コイルは、卓越した柔軟性、患者のセットアップ時間の大幅な短縮、PhilipsのSmartSpeed AIソリューションによる最適化を実現し、その結果、高画質解像度を実現し、ヘルスケア従事者の診断の信頼性を高めます。

装置の高コスト

装置の高コストなどの要因が、世界のMRIコイル市場を阻害すると予想されます。特に資金が限られている発展途上国のヘルスケア施設では、MRIコイルの購入や維持にかかるコストが高額になる可能性があります。MRIコイルのコストは大きく異なり、新品は12,000米ドルから120,000米ドルです。それに比べ、再生コイルはより手頃な価格ですが、それでも3,000米ドルから25,000米ドルと、かなりの投資が必要です。このような出費は、特にヘルスケア資金が限られ、財政的な制約が一般的な新興諸国では、新技術の採用を遅らせる可能性があります。その結果、多くの病院が最新技術に投資するよりも、古い機器や再生コイルを採用することを選択し、地域間で診断能力に不平等が生じる可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • MRIコイルの需要増加
  • 抑制要因
  • MRIコイルの高コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• SWOT分析
• DMIの見解

第6章 コイルタイプ別

• 高周波コイル
• 勾配コイル
• 表面コイル
• その他

第7章 用途別

• 神経
• 心臓血管
• 脊椎と筋骨格
• 小児科
• 胸部
• 腹部
• その他

第8章 エンドユーザー別

• 病院
• 画像診断センター
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• GE HealthCare
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Koninklijke Philips N.V
• Siemens Healthcare Private Limited
• Canon Medical Systems
• Esaote SPA
• MR Instruments, Inc.
• RAPID MR International
• ScanMed, LLC
• Bruker
• Tesla Engineering Ltd

第12章 付録

The global MRI coils market reached US$ 9.26 billion in 2024 and is expected to reach US$ 18.18 billion by 2033, growing at a CAGR of 8.1% during the forecast period 2025-2033.

MRI coils are critical components of Magnetic Resonance Imaging (MRI) systems, enabling high-quality diagnostic images of diverse body areas. MRI coils are specialized devices that work similarly to antennas. They are made up of one or more loops of copper wire that help create and receive radiofrequency (RF) signals during an MRI scan. These coils are essential to the imaging process because they enable the capturing of signals released by the body's atomic nuclei when subjected to a strong magnetic field.

MRI coils receive RF signals created by the MRI machine and transmit them to a computer, where they are processed to provide detailed images of the body's internal architecture. Coils come in a variety of designs adapted to certain anatomical locations. Some coils are frame-like and fit over the area being scanned, but others are flexible and adjust to the body's shape.

Market Dynamics: Drivers & Restraints

Increasing demand for MRI coils

The increasing demand for MRI coils is expected to be a significant factor in the growth of the global MRI coils market. The global MRI coils market is poised for significant expansion, owing mostly to the increasing demand for diagnostic imaging procedures, the rising prevalence of chronic diseases, technological advancements, and new product launches and approvals. Chronic diseases such as cardiovascular disorders, cancer, and neurological conditions are on the rise as a result of aging populations, lifestyle changes, and environmental influences.

For instance, according to the Centers for Disease Control and Prevention, around 20.1 Million adults age 20 and older have coronary artery disease, about 7.2% in the United States. According to the National Center for Biotechnology Information, 2023, Osteoporosis is the most common metabolic bone disorder globally and in tropical countries. The prevalence of osteoporosis is 30 to 50% among postmenopausal women and up to 20% in men above 50 years. Furthermore, according to the World Health Organization, 2023, diseases like cancers, chronic obstructive pulmonary diseases, asthma, diabetes, and cardiovascular diseases affect people in low- and middle-income countries, where more than three-quarters of global NCD deaths (31.4 million) occur that rounds up to 80%. Approximately 17 million people die from an NCD before age 70. The increasing prevalence of such disorders needs improved imaging techniques capable of providing deep insights into patients' health, making MRI a vital tool in modern medicine. As the prevalence of chronic diseases rises, healthcare organizations are progressively implementing MRI technologies to improve diagnostic accuracy and treatment planning.

The MRI coils market is also driven by the technical improvements that enhance the design and functionality of these devices. MRI scans are becoming more efficient and effective due to innovations including higher signal-to-noise ratios (SNRs) and faster scan times. As manufacturers create novel radiofrequency (RF) coils and gradient coils specialized to specific applications, image quality increases, which is critical for identifying complex chronic conditions. Furthermore, the incorporation of high-field MRI systems (such as 3T and 7T machines) improves imaging capabilities by allowing for crisper and more detailed pictures, which are critical in detecting subtle changes associated with chronic diseases.

For instance, in November 2023, Royal Philips, a global pioneer in health technology, launched three new MR Smart Fit coils that are ideal for their intended use. RF coils are a fundamental component of all MRI scans. The new ultra-lightweight coils offer remarkable flexibility, a significant reduction in patient setup time, and optimization with Philips' SmartSpeed AI solution, resulting in higher image quality resolution and increased diagnostic confidence for healthcare practitioners.

High costs of devices

Factors such as high costs of devices are expected to hamper the global MRI coils market. The cost of purchasing and maintaining MRI coils can be high, particularly for healthcare facilities in underdeveloped countries where funds are limited. The cost of MRI coils varies greatly, with new equipment ranging from USD 12,000 to $120,000. In comparison, reconditioned coils are more affordable but still require a significant investment, ranging from USD 3,000 to USD 25,000. These expenses can slow the adoption of new technologies, especially in developing countries where healthcare financing is limited and financial restraints are common. As a result, many hospitals may choose to employ older equipment or refurbished coils rather than invest in the most recent technology, resulting in inequalities in diagnostic capabilities between regions.

Segment Analysis

The global MRI coils market is segmented based on coil type, application, end-user, and region.

Radiofrequency Coils segment is expected to dominate the global MRI coils market share

The radiofrequency coils segment is anticipated to dominate the global MRI coils market owing to its critical role in the MRI imaging process and the increasing demand for advanced diagnostic technologies. RF coils are critical components of MRI systems, serving as both transmitters and receivers of radiofrequency signals. This dual functionality enables them to produce high-quality images of inside body structures, making them valuable in medical diagnostics.

The increased preference for non-invasive diagnostic procedures contributes to the dominance of RF coils in the MRI market. Patients increasingly prefer imaging procedures that reduce inconvenience and risk while delivering detailed information about their health issues. As a result, hospitals are investing in advanced MRI systems equipped with high-quality RF coils to meet demand. The incorporation of artificial intelligence (AI) and machine learning into MRI technology is also expected to boost the capabilities of RF coils, confirming their role in current medical diagnosis.

Continuous advances in RF coil technology are strengthening their market position. Innovations include lighter and more flexible designs that improve patient comfort during scans while also increasing imaging procedure efficiency. These advancements not only improve imaging quality but also contribute to faster diagnosis and treatment planning, which is critical for efficient chronic disease management. For instance, in May 2024, a team of scientists from the German Cancer Research Center, designed an RF coil with minimal ion attenuation, based on a cylindrical 16-rung birdcage configuration. This specific birdcage coil only has capacitors on the end rings, thereby avoiding attenuation and scattering in a large window in between. The RF coil is designed to prevent adverse effects such as ion attenuation and scattering that are caused due to highly attenuating electronic components which alter the delivered dose distribution and reduce treatment efficacy.

Geographical Analysis

North America is expected to hold a significant position in the global MRI coils market share

North America will likely account for a significant share of the global MRI coils market, owing to its advanced healthcare infrastructure, increasing prevalence of chronic diseases, and substantial investments in medical technology, technological advancements, and recent launches and approvals. The rising incidence of chronic diseases has a substantial influence on healthcare services in North America. As healthcare practitioners work to enhance early diagnosis and treatment results, demand for MRI services has increased. This development is especially noticeable in hospitals and diagnostic imaging centers, which are increasingly using powerful MRI systems with complex coils. These coils serve an important role in improving image quality and delivering specific information about the medical conditions of patients.

For instance, according to an article published by the National Institute of Health, in 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both adjuvant and metastatic settings. However, these gains are threatened by increasing incidence for 6 of the top 10 cancers.

The region's healthcare sector is highlighted by significant financial investments in new medical technologies, which has a direct impact on demand for MRI coils. These investments not only increase the availability of new diagnostic technologies but also ensure that healthcare facilities can meet the growing demand for imaging services. As hospitals and diagnostic centers strive to improve patient outcomes through early identification and intervention, they are increasingly relying on modern MRI systems with revolutionary coil technologies. This pattern is additionally facilitated by North America's high levels of healthcare spending, which make it easier to purchase advanced MRI equipment with sophisticated coils.

For instance, in June 2024, Promaxo, a developer of portable low-field MRI systems and minimally invasive robotics, received an investment from Zynext Ventures, the Venture Capital (VC) arm of Zydus Lifesciences. The investment from Zynext Ventures will enable Promaxo to expand its operations and accelerate development efforts in the field of advanced MRI technology.

Asia Pacific is growing at the fastest pace in the global MRI coils market

The Asia Pacific region is emerging as the fastest-growing market for MRI coils, owing to a combination of demographic trends, increased healthcare investment, recent launches, and a rising number of chronic diseases. The rising frequency of chronic diseases in the region of Asia-Pacific has increased the need for appropriate diagnostic imaging solutions. Cardiovascular diseases, cancer, and neurological disorders are becoming increasingly common, necessitating the use of modern imaging tools to accurately diagnose and plan treatments. The increased awareness of early diagnosis among patients and healthcare providers is driving up demand for MRI systems, which rely on high-quality coils to produce precise imaging results.

For instance, according to the National Institute of Health, the estimated number of incident cases of cancer in India for the year 2022 was found to be 14,61,427 (crude rate:100.4 per 100,000). In India, one in nine people is likely to develop cancer in his/her lifetime. Lung and breast cancers were the leading sites of cancer in males and females, respectively. Among the childhood (0-14 yr) cancers, lymphoid leukemia (boys: 29.2% and girls: 24.2%) was the leading site. The incidence of cancer cases is estimated to increase by 12.8 percent in 2025 as compared to 2020.

Competitive Landscape

The major global players in the global MRI coils market include GE HealthCare, Koninklijke Philips N.V, Siemens Healthcare Private Limited, Canon Medical Systems, Esaote SPA, MR Instruments, Inc., RAPID MR International, ScanMed, LLC, Bruker, Tesla Engineering Ltd among others.

Emerging Players

Innovatus Imaging and Time Medical Holding Co Ltd among others

Key Developments

• In November 2024, Polarean Imaging PLC received FDA 510(k) clearance for its XENOVIEW 3T chest coil to be used with GE HealthCare 3 Tesla (3T) MRI systems. The clearance allows the use of the device to support lung imaging using hyperpolarised Xenon-129 for oral inhalation in adults and children aged 12 and older. It works with GE MRI models, including the SIGNA Premier 3T and Discovery MR750 3T, equipped with multi-nuclear spectroscopy.
• In May 2024, Siemens Healthineers invested 250 million pounds ($314 million) in a facility to establish a new MRI manufacturing plant in the U.K.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global MRI coils market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Coil Type
• 3.2. Snippet by Application
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
  • 4.1.2. Increasing Demand for MRI Coil
  • 4.1.3. Restraints
  • 4.1.4. High Costs of MRI Coils
  • 4.1.5. Opportunity
  • 4.1.6. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Coil Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coil Type
  • 6.1.2. Market Attractiveness Index, By Coil Type
• 6.2. Radiofrequency Coils*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Gradient Coils
• 6.4. Surface Coils
• 6.5. Others

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Neurology*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Cardiovascular
• 7.4. Spine and Musculoskeletal
• 7.5. Pediatric
• 7.6. Breast
• 7.7. Abdominal
• 7.8. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Diagnostic Imaging Centers
• 8.4. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coil Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coil Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coil Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coil Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coil Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. GE HealthCare*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Koninklijke Philips N.V
• 11.3. Siemens Healthcare Private Limited
• 11.4. Canon Medical Systems
• 11.5. Esaote SPA
• 11.6. MR Instruments, Inc.
• 11.7. RAPID MR International
• 11.8. ScanMed, LLC
• 11.9. Bruker
• 11.10. Tesla Engineering Ltd

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us